Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil
Open Access
- 1 May 1999
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 47 (5) , 545-552
- https://doi.org/10.1046/j.1365-2125.1999.00923.x
Abstract
Aims The present study was conducted to evaluate metabolism of the enantiomers of verapamil and norverapamil using a broad range of cytochrome P450 isoforms and measure the kinet...Keywords
This publication has 20 references indexed in Scilit:
- Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*Clinical Pharmacology & Therapeutics, 1998
- Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by RifampinHepatology, 1996
- Identification of P450 enzymes involved in metabolism of verapamil in humansNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
- Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionClinical Pharmacology & Therapeutics, 1992
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991
- [8] Expression of mammalian cytochrome P450 using vaccinia virusPublished by Elsevier ,1991
- The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in manBiochemical Pharmacology, 1989
- Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.British Journal of Clinical Pharmacology, 1984
- Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatmentJournal of Molecular Medicine, 1980